AJU IB Investment Co., Ltd. — 13F Holdings & Portfolio
CIK 1710065 · latest 13F-HR filed 2026-05-08
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$30.5M
Long-equity book
6
Distinct positions
2026-03-31
Filed 2026-05-08
+2 / −3 / ↑3 / ↓0
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ARCELLX INC$11.1M +76.1%
- SUTRO BIOPHARMA INC$233.4K +115.3%
- KYMERA THERAPEUTICS INC$107.7K +7.0%
Exited Positions
- RALLYBIO CORP$4.1M
- XILIO THERAPEUTICS INC$427.5K
- RAPT THERAPEUTICS INC$421.2K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 03940C100 | $25.7M | 84.07% | 223,486 | SH |
| 2 | KYMERA THERAPEUTICS INC | KYMR | 501575104 | $1.6M | 5.36% | 19,648 | SH |
| 3 | SEER INC | SEER | 81578P106 | $1.5M | 5.05% | 816,375 | SH |
| 4 | RALLYBIO CORP | RLYB | 75120L209 | $846.2K | 2.77% | 94,334 | SH |
| 5 | SUTRO BIOPHARMA INC | STRO | 869367102 | $435.9K | 1.43% | 17,500 | SH |
| 6 | XILIO THERAPEUTICS INC | XLO | 98422T209 | $401.1K | 1.31% | 47,695 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | $30.5M | 6 | 0001140361-26-019665 |
| 2025-12-31 | 2026-02-10 | $22.8M | 7 | 0001140361-26-004468 |